Dronabinol-Acetazolamide Combination for Obstructive Sleep Apnea

Trial
100%75%50%25%0%Jun 18Jun 19Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 18 • YES 56.7%Jun 24 • YES 60.9%Jun 25 • YES 60.9%
ResolvedYES
Oracle Evidence
Resolved Date
12/1/26
Study Completion
12/1/26
Sponsor
Incannex Healthcare Ltd
Ticker
$IXHL
Type
Phase 2/Phase 3
Trial Status
Active, not recruiting
Trial Size
560
NCT
NCT06146101
Trial Description
IHL-42X is being tested in adults with obstructive sleep apnea to reduce breathing interruptions during sleep.